Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04760847 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Intermittent Fasting for Pancreatitis

Study acronym: IFPanc
StatusNot Yet Recruiting
PhaseNot applicable
Started2027-09
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 47 months later Apr 1, 2026 → Mar 2030
See other at-risk trials from H. Lee Moffitt Cancer Center and Research Institute

Amendment history

2026-09-18
Primary completion pushed: 2026-04-01 → 2030-03
Completion pushed: 2026-04-01 → 2030-03
2025-04-21
Study Status v14
Start date2025-03→2026-03
2025-01-14
Study Status v13
Start date2024-12→2025-03
2024-11-21
Study Status v12
Start date2024-10→2024-12
2024-09-30
Study Status v11
Start date2024-09-07→2024-10
Show 10 earlier versions
2024-07-31
Study Status v10
Start date2024-07-07→2024-09-07
2024-06-04
Study Status v9
Start date2024-05-07→2024-07-07
2024-04-10
Study Status v8
Primary completion date2024-04-01→2026-04-01
Completion date2024-04-01→2026-04-01
Start date2024-03-07→2024-05-07
2024-01-19
Study Status v7
Start date2023-12-07→2024-03-07
2023-07-24
Study Status v6
Start date2023-07-07→2023-12-07
2023-03-09
Study Status v5
Primary completion date2024-02-01→2024-04-01
Completion date2024-02-01→2024-04-01
Start date2023-01-07→2023-07-07
2022-07-06
Study Status v4
Start date2022-06-07→2023-01-07
2022-02-21
Study Status v3
Start date2022-02-07→2022-06-07
2022-01-18
Recruiting→Not Yet Recruiting Study Identification, Study Status, Sponsor/Collaborators, Contacts/Locations v2
Trial statusRecruiting→Not Yet Recruiting
Primary completion date2023-03-01→2024-02-01
Completion date2023-03-01→2024-02-01
Start date2021-08-07→2022-02-07
Lead sponsorUniversity Hospitals Cleveland Medical Center→H. Lee Moffitt Cancer Center and Research Institute
Study sites1 entry, revised
UniversityMoffitt HospitalsCancer Center
2021-11-26
Not Yet Recruiting→Recruiting Study Identification, Study Status, Study Description, Outcome Measures, Eligibility, Contacts/Locations v1
Trial statusNot Yet Recruiting→Recruiting
Start dateestimated 2021-03-01→confirmed 2021-08-07
Secondary endpointsdetails revised at 2 of 8 entries
Study description+80 characters
[...] liance on ketones as energy, lead to down regulation of the membrane target of rapamycin (mTOR) pathway. Much is known regarding the mTOR pathway. Down reg [...] utic medications.5 For acute, chronic pancreatitis and post-ndoscopic retrograde cholangiopancreatopgraphy (ERCP) pancreatitis, mTOR is usually activated.6 In particular, bl [...]
Study sitesdetails revised at 1 of 1 site
2021-02-15
Original filing
The purpose of this research is to compare intermittent fasting with a standard diet approach for improving the quality of life related to your pancreas disease. Our hope is to improve your symptoms and prevent you from needing to go into the hospital for pancreas-related issues.
Trial Details
NCT Number NCT04760847
Lead Sponsor H. Lee Moffitt Cancer Center and Research Institute
Conditions Pancreatitis, Pancreatitis, Acute, Pancreatitis, Chronic, Pancreas Disease, Acute Recurrent Pancreatitis
Enrollment 64 participants
Start Date 2027-09
Primary Completion 2030-03 (estimated)
Study Completion 2030-03 (estimated)
Updated on ClinicalTrials.gov 2026-09-17